Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies

Canadian Journal of Anesthesia

Volumn 57, Issue 12, 2010, Pages 1078-1088

  Doherty, Dermot R ^a,b   Pascuet, Elena ^b   Ni, Andy ^c   Stewart, Paul ^b   Splinter, William ^a   Vaillancourt, Régis ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c Clinical Epidemiology Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANESTHESIA; ARTICLE; CANADA; CHILD; CLINICAL PRACTICE; DRUG LABELING; FEMALE; HUMAN; INFANT; INTENSIVE CARE UNIT; MALE; METHODOLOGY; NEWBORN; NEWBORN INTENSIVE CARE; OFF LABEL DRUG USE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PUBLICATION; RETROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ANESTHESIA; CANADA; CHILD; CHILD, PRESCHOOL; DRUG LABELING; FEMALE; FORMULARIES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; MALE; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 79952279564     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-010-9395-0     Document Type: Article

References (20)

1. 'T Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324: 1313-4. (Pubitemid 34606775)
2. Carvalho PR, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Prescription of drugs not appropriate for children in a pediatric intensive care unit (Portuguese). J Pediatr (Rio J) 2003; 79: 397-402. (Pubitemid 37410472)
3. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009; 34: 277-87.
4. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164: 552-8. (Pubitemid 41225059)
5. Health Canada. Response to Recommendations to Health Canada of the Coroner's Jury into the Death of Ashley Marie Atkinson. Health Products and Food Branch Health Canada, (2003). Available from URL: http://www.hc-sc.gc.ca/ahc- asc/pubs/hpfb-dgpsa/death-deces-atkinson-e.html (accessed June 23rd 2010).
6. Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics 2008; 121: 530-9.
7. Canadian Pharmacists Association. (2009) Compendium of Pharmaceuticals and Specialties, 44 ed. Ottawa.
8. O'Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.
9. Barr J, Brenner-Zada G, Heiman E, et al. Unlicensed and offlabel medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 2002; 19: 67-72. (Pubitemid 34229581)
10. Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Offlabel drug use in a Pediatric Intensive Care Unit. Indian J Pediatr 2009; 76: 1113-8.
11. American Pharmacists Association. In: Taketomo CK, Hodding JH, Kraus DM, editors. Pediatric Dosage Handbook. 16th ed. OH, USA: Lexi-Comp, Inc; 2009.
12. 2008/09 Drug Handbook and Formulary (SickKids). The Hospital for Sick Children, Toronto, ON, Canada. Toronto: The Hospital for Sick Children.
13. 2009 VIDAL Drug Compendium. Issy les Moulineaux, France: UBM Medica (Groupe United Business Media).
14. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-18. (Pubitemid 44322888)
15. WHO Collaborating Centre for Drug Statistics Methodology. Available from URL: http://www.whocc.no/(accessed August 9, 2010).
16. Hornik K. The R FAQ (2010) Available from URL: http://CRAN.R-project.org/ doc/FAQ/R-FAQ.html (accessed September 2010).
17. Anderson GD, Lynn AM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy 2009; 29: 680-90.
18. Cuttini M. Proxy informed consent in pediatric research: a review. Early Hum Dev 2000; 60: 89-100.
19. Aleksa K, Koren G. Ethical issues in including pediatric cancer patients in drug development trials. Paediatr Drugs 2002; 4: 257-65. (Pubitemid 34494030)
20. Waisel DB. Moral responsibility to attain thorough pediatric drug labeling. Paediatr Anaesth 2009; 19: 989-93.